Numeric Investors’s Bellicum Pharmaceuticals BLCM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLCM
BBA
Numeric Investors's BLCM Position: Q4 2017 in Review
Numeric Investors reduced its Bellicum Pharmaceuticals (BLCM) stake by 60% in Q4 2017, selling an estimated $173K and leaving 1,186 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.
Numeric Investors first reported a position in BLCM in Q1 2015 and has held it in 7 quarters since. The position peaked at $1.36M in Q3 2015. 91 funds tracked by Wall St. Rank hold BLCM as of Q4 2017.
- Numeric Investors held 1,186 shares of Bellicum Pharmaceuticals worth $100K as of Q4 2017.
- Numeric Investors sold 1,760 Bellicum Pharmaceuticals shares in Q4 2017, an estimated $173K.
- Bellicum Pharmaceuticals made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1042 holding.
- Numeric Investors first reported a position in Bellicum Pharmaceuticals in Q1 2015 and has held it in 7 quarters since.
- Numeric Investors's Bellicum Pharmaceuticals position peaked at $1.36M in Q3 2015.
- 91 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals as of Q4 2017.
Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.